Bayer Sells Nebido To Grünenthal Amid Shift In Focus To Cell And Gene Pipeline

Will Sell For Up To €500m

 
• By Ayisha Sharma
  
The Divestment Will Generate Funds To Invest In Innovative New Therapies • Source: Shutterstock

More from Deals

More from Business